LSI USA '23 filling fast. Register Now

Pluristem Therapeutics (NasdaqCM: PSTI; TASE: PLTR)

Drug delivery platform that releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory and ischemic disea...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Pluristem Therapeutics (NasdaqCM: PSTI; TASE: PLTR) plus 5393 other startups.

Start Free 7 Day Trial Now

Learn More About Pluristem Therapeutics (NasdaqCM: PSTI; TASE: PLTR)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients